JP2009538894A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009538894A5 JP2009538894A5 JP2009512674A JP2009512674A JP2009538894A5 JP 2009538894 A5 JP2009538894 A5 JP 2009538894A5 JP 2009512674 A JP2009512674 A JP 2009512674A JP 2009512674 A JP2009512674 A JP 2009512674A JP 2009538894 A5 JP2009538894 A5 JP 2009538894A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- hydrogen
- alkyl
- imaging
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 19
- 229910052739 hydrogen Inorganic materials 0.000 claims 13
- 239000001257 hydrogen Substances 0.000 claims 13
- 238000003384 imaging method Methods 0.000 claims 11
- 150000002431 hydrogen Chemical class 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 7
- 150000002367 halogens Chemical class 0.000 claims 7
- 230000002285 radioactive effect Effects 0.000 claims 7
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 239000002243 precursor Substances 0.000 claims 5
- 125000003636 chemical group Chemical group 0.000 claims 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 4
- 238000001727 in vivo Methods 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- -1 azetidyl Chemical group 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 229910052755 nonmetal Inorganic materials 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 229910052717 sulfur Inorganic materials 0.000 claims 3
- 125000001931 aliphatic group Chemical group 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 125000003709 fluoroalkyl group Chemical group 0.000 claims 2
- 238000002372 labelling Methods 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000012453 solvate Substances 0.000 claims 2
- 125000004001 thioalkyl group Chemical group 0.000 claims 2
- 125000002733 (C1-C6) fluoroalkyl group Chemical group 0.000 claims 1
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical compound CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 150000001350 alkyl halides Chemical class 0.000 claims 1
- 125000003118 aryl group Chemical group 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 238000007336 electrophilic substitution reaction Methods 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 239000011737 fluorine Substances 0.000 claims 1
- 125000005842 heteroatom Chemical group 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000000269 nucleophilic effect Effects 0.000 claims 1
- 238000012634 optical imaging Methods 0.000 claims 1
- 125000002524 organometallic group Chemical group 0.000 claims 1
- 150000003568 thioethers Chemical class 0.000 claims 1
- 150000003573 thiols Chemical class 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0610866.6A GB0610866D0 (en) | 2006-06-02 | 2006-06-02 | Novel in vivo imaging compounds |
| PCT/GB2007/002024 WO2007141491A1 (en) | 2006-06-02 | 2007-05-31 | Tricyclic oxazepines as in vivo imaging compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009538894A JP2009538894A (ja) | 2009-11-12 |
| JP2009538894A5 true JP2009538894A5 (https=) | 2010-06-17 |
Family
ID=36694794
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009512674A Pending JP2009538894A (ja) | 2006-06-02 | 2007-05-31 | インビボイメージング化合物としての四環式オキサゼピン類 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20090317328A1 (https=) |
| EP (1) | EP2024373A1 (https=) |
| JP (1) | JP2009538894A (https=) |
| CN (1) | CN101460504A (https=) |
| GB (1) | GB0610866D0 (https=) |
| WO (1) | WO2007141491A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5324122B2 (ja) * | 2008-04-08 | 2013-10-23 | 関東電化工業株式会社 | 含フッ素アシル化アミン及びその製造方法 |
| WO2010093001A1 (ja) * | 2009-02-13 | 2010-08-19 | 国立大学法人大阪大学 | アルツハイマー病の診断方法および診断薬 |
| GB0908711D0 (en) * | 2009-05-20 | 2009-07-01 | Isis Innovation | Preparation of labelled compounds |
| DK2453953T3 (en) * | 2009-07-14 | 2018-08-06 | Sanofi Aventis Deutschland | Medication container with a flexible inner layer and a rigid outer layer |
| ES2570569T3 (es) * | 2009-09-28 | 2016-05-19 | Hoffmann La Roche | Compuestos de benzoxazepina como inhibidores de la PI3K y métodos de uso |
| US20150190534A1 (en) * | 2014-01-09 | 2015-07-09 | University Of Bern | Compounds for use as positron emission imaging agents |
| EP4212536B1 (en) | 2015-07-02 | 2025-02-19 | F. Hoffmann-La Roche AG | Benzoxazepin oxazolidinone compounds and methods of use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994258A (en) * | 1990-03-05 | 1991-02-19 | Merck & Co., Inc. | Gamma emitting, CCK-A antagonists for pancreatic imaging |
| JP2586411B2 (ja) * | 1995-03-03 | 1997-02-26 | 住友化学工業株式会社 | 放射性ベンゾジアゼピン誘導体およびその製造法 |
| AU7474998A (en) * | 1997-05-07 | 1998-11-27 | Emory University | Haloisoquinoline carboxamide |
| AUPP278498A0 (en) * | 1998-04-03 | 1998-04-30 | Australian Nuclear Science & Technology Organisation | Peripheral benzodiazepine receptor binding agents |
| AU3843899A (en) * | 1998-05-06 | 1999-11-23 | Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin, The | Apoptosis-inducing compounds |
| IE20000120A1 (en) * | 2000-02-11 | 2003-03-05 | Trinity College Dublin | Apoptosis - inducing compounds |
| GB0523506D0 (en) * | 2005-11-18 | 2005-12-28 | Hammersmith Imanet Ltd | Novel in vivo imaging compounds |
-
2006
- 2006-06-02 GB GBGB0610866.6A patent/GB0610866D0/en not_active Ceased
-
2007
- 2007-05-31 EP EP07733040A patent/EP2024373A1/en not_active Withdrawn
- 2007-05-31 WO PCT/GB2007/002024 patent/WO2007141491A1/en not_active Ceased
- 2007-05-31 CN CNA2007800202961A patent/CN101460504A/zh active Pending
- 2007-05-31 US US12/302,895 patent/US20090317328A1/en not_active Abandoned
- 2007-05-31 JP JP2009512674A patent/JP2009538894A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI765451B (zh) | 作為erk抑制劑的螺環類化合物及其應用 | |
| JP2009538894A5 (https=) | ||
| JP2010529088A5 (https=) | ||
| CN102271716B (zh) | 由甲苯磺酸酯前体合成18f-放射性标记的苯乙烯基吡啶及其稳定的药物组合物 | |
| US10512700B2 (en) | Radiohalide-labeled targeted diagnostics and therapeutics | |
| EP2388017B1 (en) | Catalytic radiofluorination | |
| JP2013528180A5 (https=) | ||
| JP2012514007A5 (https=) | ||
| CN101678129B (zh) | 用于ccr5体内成像的放射性pet试剂 | |
| RU2019142507A (ru) | Композиции, способы и системы для синтеза и применение визуализирующих средств | |
| JP2015505296A5 (https=) | ||
| RU2003114748A (ru) | Новые соединения, не являющиеся имидазолами | |
| JP2010513441A5 (https=) | ||
| WO2012161177A1 (ja) | 腫瘍の画像診断用標識誘導体 | |
| JP2013542254A (ja) | タウ病理のイメージングプローブとしての複素環式化合物 | |
| JP2007500730A5 (https=) | ||
| JP2013523621A5 (https=) | ||
| JP2012504581A5 (https=) | ||
| CN1950329B (zh) | 放射性酪氨酸衍生物、其制造方法、其使用、正电子成像用标识剂和肿瘤的恶性度评价药剂 | |
| JP2012520855A5 (https=) | ||
| JP2013507345A5 (https=) | ||
| JP2012523388A5 (https=) | ||
| JP2019507155A5 (https=) | ||
| RU2007110372A (ru) | Агенты визуализации, ингибирующие металлопротеиназу | |
| JP7209970B2 (ja) | ２－［５－（イミダゾール－１－イルメチル）ピリジン－３－イル］ベンズイミダゾール誘導体化合物、及び、これを含む医薬 |